Skip to content

PRactice of VENTilation in Critically Ill PEDiatric Patients

PRactice of VENTilation in Critically Ill PEDiatric Patients (PRoVENT-PED) - an International Multicenter Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06220825
Acronym
PRoVent-PED
Enrollment
2500
Registered
2024-01-24
Start date
2024-04-01
Completion date
2034-04-01
Last updated
2025-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Respiratory Failure

Keywords

Ventilation practice, Critically ill children, PARDS, Mechanical ventilation

Brief summary

The goal of this worldwide observational study is to investigate ventilation practice in critically ill pediatric patients. The main questions it aims to answer are: 1. What is the global current practice of ventilatory support in critically ill pediatric patients? 2. Which potentially modifiable factors related to ventilation are associated with outcome? Participating pediatric intensive care units will gather detailed information about ventilation practice and outcome, such as duration of ventilatory support, length of ICU stay and ICU mortality.

Detailed description

Rationale: Studies on ventilatory support in critically ill pediatric patients remain scarce and much of the current clinical practice is based upon experience and data originating from critically ill adult patients. Objectives: 1. To describe the worldwide practice of ventilatory support in critically ill pediatric patients; and 2. To identify potentially modifiable ventilation parameters that have independent associations with outcome. Hypothesis: 1. Practice of ventilatory support in critically ill pediatric patients varies substantially worldwide; and 2. Potentially modifiable factors related to ventilation have independent associations with outcome in critically ill pediatric patients. Study design: International, multicenter, observational cohort study in critically ill pediatric patients. Each year, data will be collected in two predefined 4-week periods, one in the winter season and one in the summer season. A third 4-week period will be in case of epi- or pandemics. The study is designed to run for 10 years; within these 10 years, there will be subprojects during pre-defined periods. Centers have the option to opt out during certain time periods to make the study manageable for every participating country/center. Study population: Critically ill pediatric patients (aged 0-18) admitted to the pediatric intensive care unit (PICU) and necessitating ventilatory support \> 12 hours. Premature infants will be excluded. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Because of the observational design of the study using routinely collected data, there is no additional burden for the patient. Collection of data from ICU charts or electronic medical records systems is of no risk to the patients.

Interventions

None listed

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
CollaboratorOTHER
University Medical Center Groningen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Expected use of (non-)invasive respiratory support for at least 12 hrs

Exclusion criteria

* premature infants (i.e., postconceptional age corrected for gestational age \< 40 weeks)

Design outcomes

Primary

MeasureTime frameDescription
Tidal volumeFirst four days of (non-)invasive respiratory supportTidal volume
Mechanical powerFirst four days of (non-)invasive respiratory supportMechanical power
Driving pressureFirst four days of (non-)invasive respiratory supportDriving pressure
Positive end-expiratory pressureFirst four days of (non-)invasive respiratory supportPositive end-expiratory pressure
Plateau pressureFirst four days of (non-)invasive respiratory supportPateau pressure
Peak inspiratory pressureFirst four days of (non-)invasive respiratory supportPeak inspiratory pressure

Secondary

MeasureTime frameDescription
Ventilator-free days at day 28Up to 28 days following initiation of (non-)invasive respiratory supportVentilator-free days at day 28
PARDS prevalenceFirst four days of (non-)invasive respiratory supportPrevalence of PARDS per PALICC-2 definition
Duration of respiratory support (in days)Up to 28 days following initiation of (non-)invasive respiratory supportDuration of respiratory support (in days)
Length of ICU stay (in days)PICU admissionLength of ICU stay (in days)
ICU mortalityUp to 28 days following initiation of (non-)invasive respiratory supportICU mortality

Other

MeasureTime frameDescription
Type of ventilator modeFirst four days of (non-)invasive respiratory supportVentilator mode
Use of ECMO (yes/no)First four days of (non-)invasive respiratory supportUse of ECMO
Use of prone positioning (yes/no)First four days of (non-)invasive respiratory supportUse of prone positioning
Use of vasoactive infusions (yes/no)First four days of (non-)invasive respiratory supportUse of vasoactive infusions
Use of neuromuscular blocking agents (yes/no)First four days of (non-)invasive respiratory supportUse of neuromuscular blocking agents
Type of ventilatory supportFirst four days of (non-)invasive respiratory supportType of ventilatory support
Use of sedative and/or analgesic drugs (yes/no)First four days of (non-)invasive respiratory supportUse of sedative and/or analgesic drugs

Countries

Netherlands

Contacts

Primary ContactRelin Van Vliet, MSc
r.vanvliet@amsterdamumc.nl0031627560257
Backup ContactDavid MP van Meenen, MD PhD
d.m.vanmeenen@amsterdamumc.nl

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026